Song L, Yuan X, Huang S, Zhang Y, et al. iGlarLixi provides improved early glycaemic control after 12 weeks of treatment compared with basal insulin in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan-O-AP and LixiLan-L-CN studies. Diabetes Obes Metab 2025 Feb 27. doi: 10.1111/dom.16260.
PMID: 40013432